TY  - JOUR 
AU  - Jorge Fernández, Monica
PY  - 2014
SN  - 0007-0920
UR  - http://hdl.handle.net/20.500.11940/7332
LA  - eng
TI  - First-line bevacizumab and capecitabine-oxaliplatin in elderly patients with mCRC: GEMCAD phase II BECOX study
DO  - 10.1038/bjc.2014.346
T2  - BRITISH JOURNAL OF CANCER
M2  - 241
VL  - 111
ER  -